The effect of vitamin D on people with prediabetes
| ISRCTN | ISRCTN51643592 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN51643592 |
| Secondary identifying numbers | 1278/6-10-15 |
- Submission date
- 27/01/2022
- Registration date
- 28/01/2022
- Last edited
- 14/02/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Background and study aims
Prediabetes is a serious health condition where blood sugar levels are higher than normal, but not high enough yet to be diagnosed as type 2 diabetes. Data are scarce on the effectiveness of vitamin D at improving the blood sugar levels of elderly people with prediabetes. The aim of this study is to investigate the effect of vitamin D supplementation on blood sugar markers of Greek people with prediabetes aged 60 years or above, over a 12-month period.
Who can participate?
Men and women with prediabetes aged 60 years and older living in Thessaloniki, Greece
What does the study involve?
Participants are randomly allocated to a weekly vitamin D3 dose of 25,000 IU or nothing on top of lifestyle measures. Body measurements and blood sugar markers are assessed at the start of the study and after 3, 6 and 12 months.
What are the possible benefits and risks of participating?
The possible benefits include an improvement in vitamin D status, which is known to be important for skeletal health, particularly among the elderly, and an improvement in blood sugar markers in supplemented individuals. There are no expected risks.
Where is the study run from?
Aristotle University (Greece)
When is the study starting and how long is it expected to run for?
February 2016 to February 2020
Who is funding the study?
Investigator initiated and funded
Who is the main contact?
Assoc. Professor Kalliopi Kotsa
kkalli@auth.gr
Contact information
Principal Investigator
First Department of Internal Medicine
Medical School
Aristotle University of Thessaloniki
AHEPA University Hospital
1 St. Kiriakidi Street
Thessaloniki
54636
Greece
 ORCID ID |
0000-0003-2376-740X |
|---|---|
| Phone | +30 (0)6932045201 |
| kkalli@auth.gr |
Study information
| Study design | Interventional 12-month open-label single-centre randomized-controlled study |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Community |
| Study type | Prevention |
| Participant information sheet | No participant information sheet available |
| Scientific title | The effect of vitamin D supplementation on glycemic status of elderly people with prediabetes: a 12-month open-label, randomized-controlled study |
| Study objectives | It is hypothesized that vitamin D supplementation has optimal effects on glycemic markers of elderly people with prediabetes. |
| Ethics approval(s) | Approved 19/04/2016, the Ethics Committee of the Aristotle University of Thessaloniki (Faculty of Medicine, Aristotle University of Thessaloniki, University Campus, Building of the new Amphitheatres, PC 54124, Thessaloniki, Greece; +30 (0)2310999338, bioethics@med.auth.gr, sakkageor@auth.gr), ref: 260/19-04-16 |
| Health condition(s) or problem(s) studied | Prevention of the development of diabetes in people with prediabetes |
| Intervention | Among the 381 individuals initially screened, 105 were diagnosed with prediabetes and 90 eventually met the inclusion criteria and agreed to participate. They were randomly assigned by computer code to receive a weekly dose of vitamin D3 of 25,000 IU in the form of oral solution (intervention group; n = 45) or nothing (control group; n = 45). Both groups were advised to adopt specific lifestyle changes according to the ADA recommendations for the prevention of diabetes, namely at least 150 min per week of moderate-intensity aerobic activity, and target a 7% weight loss within 3 months by adhering to the Mediterranean diet. Participants were seen monthly for the first 3 months of the follow-up period and subsequently every 3 months until the end of the study. Each visit included a consultation with both a physician and a dietitian to resolve potential issues, while subjects were contacted by telephone monthly by members of the research team to ensure adherence to the diet and compliance with supplement use. The latter was also determined from the number of empty medication boxes returned at each visit. Anthropometric and glycemic markers were assessed at baseline, 3, 6, and 12 months. |
| Intervention type | Supplement |
| Primary outcome measure | 1. Fasting glucose measured using the Cobas INTEGRA clinical chemistry system at 3, 6, and 12 months after the start of vitamin D supplementation 2. Glycated hemoglobin values measured using the ADAMS HA-8160 high-performance liquid chromatography method at 3, 6, and 12 months after the start of vitamin D supplementation |
| Secondary outcome measures | 1. Percentage of total participants who progressed to diabetes or returned to normoglycemia based on fasting glucose and 2 h glucose in 75 g oral glucose tolerance test (OGTT) values at 12 months after the start of vitamin D supplementation 2. Anxiety measured with the State-Trait Anxiety Inventory tool at 6 and 12 months after the start of vitamin D supplementation 3. Depression measured with the Patient Health Questionnaire-9 tool at 6 and 12 months after the start of vitamin D supplementation |
| Overall study start date | 01/02/2016 |
| Completion date | 01/02/2020 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Senior |
| Lower age limit | 60 Years |
| Sex | Both |
| Target number of participants | 70 |
| Total final enrolment | 90 |
| Key inclusion criteria | 1. Men and women with prediabetes aged 60 years and older 2. Listed on the registry of the Open Care Center for the Elderly of the Municipality of Eastern Thessaloniki, Greece. 3. Prediabetes diagnosed according to the criteria of the American Diabetes Association (ADA), either by impaired fasting plasma glucose (IFG) [fasting plasma glucose (FPG): 100–125 mg/dl] or impaired glucose tolerance (IGT) [2-h plasma glucose in 75 g oral glucose tolerance (OGTT): 140–199 mg/dl] or by values of glycated hemoglobin (HbA1c) between 5.7% (39 mmol/mol) and 6.4% (46 mmol/mol) |
| Key exclusion criteria | 1. Pre-existing diabetes mellitus 2. Normal glucose levels 3. Any medical conditions that could potentially affect the outcomes of the study or increase the risk of complications following vitamin D supplementation (nephrolithiasis, hypercalcemia, hyperparathyroidism, sarcoidosis, and chronic renal disease [stages 3 to 5 / estimated glomerular filtration rate <45 ml/min/1.73m²]) 4. Malignancies 5. Inflammatory or rheumatic diseases 6. Psychiatric conditions |
| Date of first enrolment | 01/10/2017 |
| Date of final enrolment | 01/02/2019 |
Locations
Countries of recruitment
- Greece
Study participating centre
First Department of Internal Medicine
Medical School
Aristotle University of Thessaloniki
1 St Kiriakidi Street
Thessaloniki
54636
Greece
Sponsor information
University/education
University Campus
Thessaloniki
54124
Greece
| Phone | +30 (0)2310 996000 |
|---|---|
| kateri@auth.gr | |
| Website | https://www.auth.gr/en |
"ROR" |
https://ror.org/02j61yw88 |
Funders
Funder type
Other
No information available
Results and Publications
| Intention to publish date | 15/02/2022 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Available on request |
| Publication and dissemination plan | The study has already submitted for publication in a PubMed-indexed journal and is currently under review having already received a decision for minor revisions. |
| IPD sharing plan | Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | 15/02/2022 | 16/02/2022 | Yes | No | |
| Results article | 20/09/2022 | 14/02/2024 | Yes | No |
Editorial Notes
14/02/2024: Publication reference added.
16/02/2022: Publication reference added.
28/01/2022: Trial's existence confirmed by the ethics committee of Aristotle University.
